Microfluidics Market Outlook:
Microfluidics Market size was valued at USD 30.6 billion in 2025 and is forecasted to reach a valuation of USD 130.4 billion by the end of 2035, rising at a CAGR of 15.6% during the forecast period, i.e., 2026-2035. In 2026, the industry size of microfluidics is estimated at USD 35.3 billion.
The rising need for accurate point-of-care diagnostics globally is expected to fuel the growth of the market during the forecast period. In February 2024, the U.S Food and Drug Administration revealed a rapid increase in indoor point-of-care, over-the-counter (OTC) tests for SARS-CoV-2 between 2020 and 2022. These point-of-care devices can detect diseases at lower costs, which is likely to boost the sales of microfluidics even in underdeveloped countries. Moreover, the portability of microfluidic systems allows to use of the same in underdeveloped areas to accomplish sample pretreatment, dilution, separation, mixing, detection, chemical reaction, and product extraction.
The global advancements in drug discovery and development is also expected to accelerate the growth of the market significantly. For example, in May 2025, imec and Merck announced a strategic partnership with the motive of developing an advanced MicroPhysiological Systems (MPS) platform so that efficiency in drug discovery and development can be achieved. MPS uses microfluidic technology in constructing and structuring the function of the tissues and organs that are physiological and biological.
Microfluidics Market - Growth Drivers and Challenges
Growth Drivers
- Rising demand for advanced microfluidic systems: The demand for advanced microfluidic tools and diagnostic solutions is accelerating global investments in biomedical research. For instance, in June 2024, Bio-Rad Laboratories, Inc. announced the launch of its newly developed Celselect Slides 2.0, an advanced microfluidic system that allows liquid biopsy samples processing and facilitates the enhancement of capture of rare cells and circulating tumor cells (CTC). In extremely small volumes, fluids are used by microfluidic systems, leading to reduced reagent and consumption of sample. This results in the reduction of costs required for biomedical research and wastage, which boosts the demand for microfluidic systems.
- Government support for development of microfluidic systems: Government support in the form of financial grants for the companies involved in the development of microfluidic systems is fueling the microfluidic market growth significantly. As reported by the U.S Food and Drug Administration (FDA) in August 2024, it funded the Pediatric Device Consortia (PDC) to accelerate the development of pediatric medical devices through advocacy, laboratory testing, and others. The development of pediatric medical devices boosts the need for microfluidics, as such systems are helpful to create high-throughput and miniaturize medical devices cost-effectively. These devices can be used in the delivery of drugs, performing diagnostic tests, and screening for diseases.
- The rising prevalence of chronic diseases: The need for modeling and diagnosing diseases, including cancer, cardiovascular, neurological, autoimmune, and respiratory disorders, due to their rising prevalence and drug development to treat these health anomalies, is leading to the development of microfluidics. As per a report by the WHO published in June 2025, the respiratory health crisis encompassing asthma, COPD, and other lung diseases is increasing due to air pollution and tobacco. Similarly, diseases like cancer are also remaining the global cause of morbidity and mortality.
Challenges
- High expenses in the manufacturing of microfluidics: The implementation of precise manufacturing techniques is integral to balancing the quality and cost-quality of microfluidics, and access to advanced materials. Glass and silicon are advanced materials required for the fabrication of microfluidic chips in the manufacturing of microfluidics, while polymer has become a material of choice in the industry. The high cost of materials influences the risk of a lower profit margin in the business of microfluidics.
- Lack of standardization and vulnerability of old systems: The compatibility of the microfluidics devices can vary from platform to platform due to a lack of standardization, raising concerns among potential users. The emergence of novel microfluidic-enabled medical devices is likely to replace the traditional macroscale systems. This is likely to lead to sudden fluctuation in the demand for conventional microfluidic systems and make the manufacturers vulnerable to collapse.
Microfluidics Market Size and Forecast:
| Report Attribute | Details |
|---|---|
|
Base Year |
2025 |
|
Forecast Year |
2026-2035 |
|
CAGR |
15.6% |
|
Base Year Market Size (2025) |
USD 30.6 billion |
|
Forecast Year Market Size (2035) |
USD 130.4 billion |
|
Regional Scope |
|
Microfluidics Market Segmentation:
Technology Segment Analysis
The lab-on-a-chip technology segment is expected to acquire a revenue share of 34.2% during the forecast period. The capability of miniaturized devices like lab-on-a-chip technology to offer a solution for arranging severe sample biochemical and biological assessments in a single platform is likely to accelerate the demand for microfluidics. Companies are also launching advanced lab-on-a-chip (LOC) technologies, increasing market accessibility. In March 2025, Dynamic42 made an announcement of the development of the tumor-on-chip model, an evolution of the lab-on-a-chip technology, which is effective in producing a complex microenvironment of aggressive pancreatic ductal adenocarcinoma (PDAC).
Application Segment Analysis
The medical application segment is expected to witness robust growth, accounting for a market share of 82.1% by the end of 2035, owing to the cost-effectiveness and positive impact of using microfluidics for diagnostic purposes. The use of microfluidics for medical purposes streamlines the diagnostic and other relevant processes, which leads to reduced expenses and chemical consumption. Moreover, medical institutions are not only adopting microfluidics but also developing advanced microfluidic devices. For instance, in February 2024, the academic hospital network and health researcher institute in Canada, Unity Health Toronto, the National Research Council of Canada (NRC), and the University of Toronto announced a strategic partnership for the development of cutting-edge microfluidic devices.
End use Segment Analysis
The hospitals and diagnostic centers segment is expected to account for a remarkable market share by 2035, owing to the rising adoption of advanced microfluidic systems and improving healthcare infrastructure and funding. The demand for quicker and more accurate diagnostic processes is likely to influence hospitals and diagnostic centers to offer point-of-care testing procedures.
Support from the government in the production of raw materials, key elements, and accessories, including microfluidics required in the manufacturing of medical devices, is likely to fuel the production of microfluidics. For example, in November 2024, the government of India announced the sub-scheme for common facilities for medical device clusters with the motive of providing financial assistance to medical device clusters involved in the development of medical infrastructural facilities.
Our in-depth analysis of the global market includes the following segments:
|
Segments |
Subsegments |
|
Material |
|
|
Application |
|
|
Technology |
|
|
End use |
|
Vishnu Nair
Head - Global Business DevelopmentCustomize this report to your requirements — connect with our consultant for personalized insights and options.
Microfluidics Market - Regional Analysis
North America Market Insights
The North America microfluidics market is anticipated to account for a market share of 44.3% during the forecast period, due to effective investments in research and development activities and the presence of leading companies. For example, in August 2025, a leading supplier of health technology, Philips, announced investments of over USD 150 million in the expansion of innovation in AI-powered health technology, including the establishment of manufacturing and R&D. This can lead to more advancements in AI-powered microfluidic systems.
The microfluidic market in the U.S is expected to witness a steady expansion at a significant CAGR, on account of the rising prevalence of chronic diseases. As reported by the Centers for Disease Control and Prevention (CDC) in April 2024, 6 in every 10 people have at least one chronic disorder, and every 4 out of 10 people suffer from two or more chronic disorders in the U.S. The rapid development of lab-on-a-chip and organ-on-a-chip technologies, supported by the U.S government, accelerates the market growth significantly as well.
Canada microfluidics market is anticipated to experience a continuous expansion at a significant CAGR, due to the presence of a strong research ecosystem. The government also initiates collaboration of key players in relevant research and development. In March 2023, the government confirmed the continuation of British Columbia as the hub of the nation’s immune-engineering and biomanufacturing, led by the University of British Columbia. This institution brings national, provincial, and international partners to the table for research and development. The motive is to position Canada as the epicenter of the manufacturing and development of next-generation immune-based therapeutics. The development of next-generation immune-based therapeutic needs microfluidics for simultaneous and high-throughput immunity testing.
Asia Pacific Market Insights
The Asia Pacific microfluidics market is expected to account for a significant revenue share by the end of 2035, owing to the growing prevalence of chronic disorders, including COPD, cardiovascular diseases, cancer, and others. This has led to investment in research on the prevention of chronic diseases. For instance, in April 2023, the government of Australia revealed an investment of USD 5.7 million as research grants for four projects, aimed at fostering research collaboration focused on the prevention of chronic diseases across Asia Pacific and Australia. The use of microfluidics is integral for diagnostic and therapeutic purposes in the development of advanced treatment for chronic diseases.
The microfluidics market in China is expected to witness rapid growth, with the acquisition of a significant revenue share by 2035, due to the increasing popularity of point-of-care testing. As revealed by the National Institutes of Health (NIH)'s National Library of Medicine (NLM) in July 2024, POCT HbA1c has been proven as a viable and cost-effective testing method for type 2 diabetes in both urban and rural areas across China. Robust manufacturing of microfluidics is also expected to fuel the market growth. This ensures the consistency in supply of microfluidics across all the applicable industrial settings, whenever required.
The microfluidics market in India is expected to account for a significant revenue share by the end of 2035, due to growing investment in R&D related to the pharmaceuticals. Pharmaceutical companies in the country are initiating significant investments in expanding their R&D centers and serving people with early-stage discovery and promising molecules. With the rising need for drug discovery, the demand for microfluidic systems is likely to increase. The preference for personalized medicine in India is also fueling the market growth. This boosts the use of the microfluidic devices as the instruments for the production of personalized medicine, owing to the capacity to perform quick diagnostic tests using smaller volumes of sample, reducing costs, displaying high resolution, and being incorporated with automation technology.
Europe Market Insights
Europe is anticipated to expand at a significant revenue CAGR by the end of 2035, due to access to adequate funding for healthcare innovation. For example, under the EU State aid rules, the European Commission approved funding of USD 469.0 million in July 2025 for projects related to innovation in medical devices. Adequate funding for innovation in medical devices expands the scope for further enhancement of innovation in designing and manufacturing microfluidic devices. The involvement of medical institutions in strengthening their point-of-care presence also fuels the demand for microfluidic systems. In January 2025, bioMérieux announced the acquisition of SpinChip Diagnostics with the motive of strengthening its point-of-care presence.
Germany is expected to lead the market in Europe, expanding at a significant CAGR during the forecast period, owing to the rising aging population. As per the forecast by the American Association of Retired Persons, the population in Germany aged 65 and over is likely to increase by 41% by the end of 2050. This indicates that the need to perform diagnostic tests is likely to increase, fueling the demand for microfluidic systems. In addition, the global leadership of Germany in microfluidic innovation is expected to accelerate the advancement of microfluidic systems.
The UK microfluidic market is anticipated to go through a rapid expansion at a remarkable CAGR throughout the forecast period, due to the growing preference for easily accessible and timely medical care. Support from the government authorities in innovation for medical solutions also fuels the demand for microfluidics. In February 2025, NICE announced the Medicines and Medical Devices (MMD) Access Initiative, a collaboration across four countries to boost innovation in medical solutions. Such initiatives to fill the gaps in the market are likely to fuel the use of microfluidic devices.
Microfluidics Market Players:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The global microfluidics market is highly competitive. The dominance of a few key players in terms of share makes the market fragmented as well. The competitors in the microfluidic market are also seen to take strategic initiatives, including collaborations, acquisitions, and the launch of advanced microfluidic items, and this drives the expansion of the market significantly. Research and development is at the core of all the key market players due to the need to focus on continuous innovation.
Below are the key players who are dominating the global market:
|
Company Name |
Country of Origin |
Market Share (%) |
|
Agilent Technologies |
U.S. |
12.3 |
|
Thermo Fisher |
U.S. |
11.4 |
|
Illumina |
U.S. |
8.2 |
|
Micronit |
Netherlands |
5 |
|
Dolomite Microfluidics |
UK |
xx |
|
Bio-Rad Laboratories |
U.S. |
xx |
|
Abbott |
U.S. |
xx |
|
Elveflow |
France |
xx |
|
BD |
U.S. |
xx |
|
Standard BioTools |
U.S. |
xx |
|
PerkinElmer's |
U.S. |
xx |
|
Danaher Corporation |
Netherlands |
xx |
|
Qiagen N.V. |
Netherlands |
xx |
|
Hurel Corporation |
U.S. |
xx |
|
Fluidigm Corporation |
U.S. |
xx |
Below are the areas covered for each company in the microfluidics market:
Recent Developments
- In August 2025, researchers associated with the Indian Institute of Technology Madras announced the development of ε-µD, a microfluidic chip, effective for rapid antibiotic susceptibility testing.
- In January 2025, ibidi expanded its portfolio of microfluidics by adding the newly developed µ-Plate 6 Well and the µ-Plate 6 Well Glass Bottom to the µ-Plate product line.
- In June 2024, Bio-Rad announced the launch of New Celselect Slides, a microfluidic-enabled design, capable of increasing efficiency in the circulating tumor cell capture.
- In November 2024, Idex Corporation launched the microfluidics-incorporated MP350 Microlyser in India. The launch was the outcome of the two years of efforts of the company in microfluidics engineering, application, manufacturing, and marketing.
- Report ID: 8066
- Published Date: Sep 05, 2025
- Report Format: PDF, PPT
- Get detailed insights on specific segments/region
- Inquire about report customization for your industry
- Learn about our special pricing for startups
- Request a demo of the report’s key findings
- Understand the report’s forecasting methodology
- Inquire about post-purchase support and updates
- Ask About Company-Level Intelligence Additions
Have specific data needs or budget constraints?
Inquiry Before BuyingFrequently Asked Questions (FAQ)
Microfluidics Market Report Scope
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Connect with our Expert
